Compare AXON & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | IQV |
|---|---|---|
| Founded | 1993 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Ordnance And Accessories | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2B | 28.6B |
| IPO Year | 2001 | 2013 |
| Metric | AXON | IQV |
|---|---|---|
| Price | $442.63 | $181.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | ★ $758.80 | $227.13 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | ★ 2.05 | 1.61 |
| Revenue | $2,779,536,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $31.50 | $6.77 |
| Revenue Next Year | $28.95 | $5.89 |
| P/E Ratio | $218.05 | ★ $112.34 |
| Revenue Growth | 33.47 | ★ 41.60 |
| 52 Week Low | $339.01 | $153.23 |
| 52 Week High | $885.92 | $247.05 |
| Indicator | AXON | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 53.62 |
| Support Level | $403.48 | $176.99 |
| Resistance Level | $597.57 | $182.20 |
| Average True Range (ATR) | 30.71 | 6.84 |
| MACD | -1.20 | 0.11 |
| Stochastic Oscillator | 47.27 | 64.50 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.